GlassScriptPhysician profile
John Clarence Lipham
NPI 1639100845
$941,957.13
in general payments reported to CMS, 2019-2025
22 companies · $73K in 2025
The $73K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344K · 2020: $133K · 2021: $63K · 2022: $87K · 2023: $131K · 2024: $111K · 2025: $73K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $260K · Travel and Lodging: $33K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $6,536 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $259,925.00 |
| Travel and Lodging | $32,872.05 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,312.00 |
| Food and Beverage | $6,535.66 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $536,651.76 | 2019-2025 | Linx Reflux Management System, Linx Reflux Management System |
| Ethicon US, LLC | $239,622.91 | 2019-2025 | Harmonic, Enseal, Linx Reflux Management System |
| Ethicon INC. | $102,300.57 | 2019-2025 | Linx Reflux Management System |
| Enterra Medical, INC. | $25,269.90 | 2023-2025 | |
| Laborie Medical Technologies Corp. | $19,822.49 | 2024-2025 | Alphaone |
| Colorado Therapeutics LLC | $7,000.00 | 2020 | |
| Medtronic, INC. | $5,248.51 | 2021-2025 | Beacon, Signia |
| Intuitive Surgical, INC. | $4,745.72 | 2019-2023 | Da Vinci Surgical System |
| Endogastric Solutions, INC | $333.18 | 2019-2022 | |
| Covidien LP | $312.63 | 2019-2020 | |
| Evoendo, INC | $170.52 | 2025 | |
| Ambu INC. | $144.63 | 2023 | |
| Ethicon Endo-Surgery INC. | $67.30 | 2024 | Linx Reflux Management System |
| Davol INC. | $56.25 | 2021 | |
| Medtronic USA, INC. | $42.63 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $39.81 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Boston Scientific Corporation | $31.51 | 2019 | |
| Acell, INC. | $24.69 | 2019 | |
| Baxter Healthcare | $24.41 | 2020 | |
| Smith+Nephew, INC. | $18.02 | 2020 | |
| Vioptix INC | $16.45 | 2025 | |
| Sirtex Medical INC | $13.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$47,640.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lipham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.